XERS earnings
Xeris Biopharma (XERS) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
XERS earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | -0.18 | 0.01 | -1582.70% | $92.10M |
| Q1 2026 | May 7, 2026 | 0.01 | -0.00 | 464.96% | $83.13M |
| Q4 2025 | Mar 2, 2026 | 0.06 | 0.03 | 100.00% | $85.81M |
| Q3 2025 | Nov 6, 2025 | 0.00 | 0.01 | -65.00% | $74.38M |
| Q2 2025 | Aug 7, 2025 | -0.01 | -0.03 | 66.67% | $71.54M |
| Q1 2025 | May 8, 2025 | -0.06 | -0.07 | 14.29% | $60.12M |
| Q4 2024 | Mar 6, 2025 | -0.03 | -0.08 | 62.50% | $60.10M |
| Q3 2024 | Nov 8, 2024 | -0.06 | -0.09 | 33.33% | $54.27M |
| Q2 2024 | Aug 8, 2024 | -0.10 | -0.11 | 9.09% | $48.06M |
| Q1 2024 | May 9, 2024 | -0.14 | -0.12 | -16.67% | $40.64M |
| Q4 2023 | Mar 6, 2024 | -0.10 | -0.09 | -11.11% | $44.39M |
| Q3 2023 | Nov 9, 2023 | -0.09 | -0.12 | 25.00% | $48.32M |
| Aug 8, 2023 | -0.14 | -0.13 | -7.69% | – | |
| May 9, 2023 | -0.12 | -0.17 | 29.41% | – | |
| Mar 8, 2023 | -0.10 | -0.16 | 37.50% | – | |
| Nov 9, 2022 | -0.14 | -0.17 | 17.65% | – | |
| Aug 10, 2022 | -0.19 | -0.23 | 17.39% | – | |
| May 11, 2022 | -0.25 | -0.24 | -4.17% | – | |
| Mar 10, 2022 | -0.42 | -0.21 | -100.00% | – | |
| Nov 10, 2021 | -0.36 | -0.37 | 2.70% | – |
- XERS reports next on Nov 5, 2026, with EPS of 0.02 expected.
- XERS beat EPS estimates in 21 of its last 33 reports.
Updated 2026-11-02 23:14 UTC